Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

SCM to Support BTG NDA

Published: Friday, April 26, 2013
Last Updated: Friday, April 26, 2013
Bookmark and Share
Will provide scale up for Varisolve launch.

SCM Pharma will assist BTG in preparation for the commercial launch of Varisolve® (polidocanol endovenous microfoam (PEM)), after providing clinical development consultancy for the product for several years.

The UK-based contract development and manufacturing organization (CDMO) has worked with specialist healthcare company BTG since 2005, assisting with clinical studies through to the recent pivotal Phase III clinical trial supply.

PEM is being developed by BTG as a comprehensive treatment for the appearance and symptoms of varicose veins. In the US alone over 40 million patients suffer from varicose veins.

To date, SCM Pharma has supported BTG with process development, sterile manufacturing, packaging and distribution to trial sites in the US.

The CDMO will now be named on the New Drug Application (NDA) for PEM as a commercial supplier and is prepared to further support BTG throughout the NDA review process.

Dianne Sharp, managing director at SCM Pharma, said: “We are very proud to be supporting BTG with its NDA for Varisolve®, as it is a product that we have helped them develop for many years.

“The complexities involved in developing, processing and producing this product illustrates the type of work we do here at SCM Pharma. Working with novel products, difficult processes and applications and often dangerous substances and APIs at relatively smaller scale is very much our sweet spot.”

SCM Pharma is an award-wining manufacturer specializing in the sterile production of products for clinical trials along with the supply of licensed drugs in niche commercial markets.

It is currently gearing up for the opening of its new commercial contract manufacturing facility that will reinforce its expertise in vial, ampoule and syringe filling, particularly when dealing with highly potent and toxic products that require aseptic filling.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

MHRA Approval for CDMO’s Commercial Facility
To supply licensed commercial products and aid clinical projects.
Thursday, June 20, 2013
MHRA Approves New SCM Pharma Commercial Facility
SCM Pharma’s new £6m ($10m) pharmaceutical contract manufacturing facility has been given the go ahead.
Thursday, June 20, 2013
Vial Filling Boost at SCM
UK-based CDMO invests over £500k in new vial filling equipment.
Thursday, March 15, 2012
SCM to Deliver Vial Filling Project
BrePco selects CDMO to initially produce clinical batches for eight clinical trial sites.
Friday, February 10, 2012
Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos